Arbutus Biopharma Corporation ABUS Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's common stock?
- Arbutus Biopharma Corporation (ABUS) reported common stock of $1.44B in Q1 2026.
- How has Arbutus Biopharma Corporation's common stock changed year-over-year?
- Arbutus Biopharma Corporation's common stock increased by 2.0% year-over-year, from $1.42B to $1.44B.
- What is the long-term trend for Arbutus Biopharma Corporation's common stock?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's common stock has grown at a 7.6% compound annual growth rate (CAGR), from $985.94M to $1.42B.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).